LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 15

Search options

  1. Article ; Online: Primera experiencia en México con el uso de plasmaféresis y rituximab en el tratamiento del rechazo humoral en trasplante cardiaco.

    Inzunza-Cervantes, Gustavo / Cigarroa-Lopéz, José A / Tepayotl-Aponte, Antonio / Martínez-Castro, Raúl / Magaña-Serrano, José A / Ivey-Miranda, Juan B

    Archivos de cardiologia de Mexico

    2024  Volume 94, Issue 2, Page(s) 247–250

    Title translation First experience in Mexico with plasmapheresis and rituximab treating humoral rejection in heart transplant.
    Language Spanish
    Publishing date 2024-02-08
    Publishing country Mexico
    Document type Journal Article
    ZDB-ID 2059019-2
    ISSN 1665-1731 ; 1665-1731
    ISSN (online) 1665-1731
    ISSN 1665-1731
    DOI 10.24875/ACM.23000149
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Recommendations for the care of patients with heart failure and COVID-19.

    Cigarroa-López, José A / Magaña-Serrano, José A / Álvarez-Sangabriel, Amada / Ruíz-Ruíz, Vicente / Chávez-Mendoza, Adolfo / Méndez-Ortíz, Arturo / León-González, Salvador / Guízar-Sánchez, Carlos / Gutiérrez-Fajardo, Pedro / Alcocer-Gamba, Marco A

    Archivos de cardiologia de Mexico

    2020  Volume 90, Issue Supl, Page(s) 26–32

    Abstract: The COVID-19 pandemic decreed by the World Health Organization (WHO) since March 12, 2020 is wreaking havoc globally and it is a true economic, social and health challenge. Although the clinical manifestations of COVID-19 are respiratory symptoms, some ... ...

    Title translation Recomendaciones para la atención de pacientes con insuficiencia cardiaca y COVID-19.
    Abstract The COVID-19 pandemic decreed by the World Health Organization (WHO) since March 12, 2020 is wreaking havoc globally and it is a true economic, social and health challenge. Although the clinical manifestations of COVID-19 are respiratory symptoms, some patients also have cardiological symptoms. Among patients with cardiological conditions2 they represent a group of higher risk and, in fact, they are a particularly vulnerable group, due to their higher risk of contagion and greater severity in case of acquiring the disease1 those with heart failure (HF), including heart transplant (CT) and ventricular assists, as well as patients with pulmonary arterial hypertension (PAH). HF is the main chronic cardiovascular disease and patients in this group are the most vulnerable for the development of more serious clinical symptoms after suffering the infection, and to a greater extent cases with advanced HF3. In fact, HF is one of the most frequent complications in patients with COVID-194. Likewise, transplant patients who require immunosuppressants to avoid graft rejection, constitute a population especially susceptible to infection and to develop more serious processes. This situation has made the National Association of Cardiologists of Mexico (ANCAM) and the Mexican Society of Cardiology (SMC) together with their respective chapters, have prepared the following recommendations for medical personnel, who participate in the care of this special group of patients in the different clinical settings, who suffer or not, of COVID-19.
    MeSH term(s) COVID-19 ; Cardiovascular Diseases/physiopathology ; Cardiovascular Diseases/therapy ; Cardiovascular Diseases/virology ; Coronavirus Infections/complications ; Coronavirus Infections/epidemiology ; Coronavirus Infections/virology ; Heart Failure/physiopathology ; Heart Failure/therapy ; Heart Failure/virology ; Humans ; Mexico ; Pandemics ; Pneumonia, Viral/complications ; Pneumonia, Viral/epidemiology ; Pneumonia, Viral/virology ; Risk Factors ; Severity of Illness Index
    Keywords covid19
    Language English
    Publishing date 2020-06-10
    Publishing country Mexico
    Document type Journal Article
    ISSN 1665-1731
    ISSN (online) 1665-1731
    DOI 10.24875/ACM.M20000060
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Clinical practice guidelines for diagnostic and treatment of the chronic heart failure.

    Pavía-López, Abel A / Magaña-Serrano, José A / Cigarroa-López, José A / Chávez-Mendoza, Adolfo / Mayorga-Butrón, José L / Araiza-Garaygordobil, Diego / Ivey-Miranda, Juan B / Méndez-Machado, Gustavo F / González-Godínez, Héctor / Aguilera-Mora, Luisa F / Jordán-Ríos, Antonio / Olmos-Domínguez, Luis / Olalde-Román, Marcos J / Miranda-Malpica, Emma M / Vázquez-Ortiz, Zuilma / Rayo-Chávez, Jorge / Mendoza, Alexandra A / Márquez-Murillo, Manlio F / Chávez-Leal, Sergio A /
    Gabriel, Amada Álvarez-San / Silva-García, Marissa A / Pacheco-Bouthiller, Alex D / Aldrete-Velazco, Jorge A / Guizar-Sánchez, Carlos A / Gaxiola-López, Efraín / Guerra-López, Arturo / Figueiras-Graillet, Lourdes / Sánchez-Miranda, Gustavo / Mendoza-Zavala, Genaro H / Aceves-García, Moisés / Chávez-Negrete, Adolfo / Arroyo-Hernández, Marisol / Montaño-Velázquez, Bertha B / Romero-Moreno, Luis F / Baquero-Hoyos, María M / Velasco-Hidalgo, Liliana / Rodríguez-Lozano, Ana L / Aguilar-Gómez, Nancy E / Rodríguez-Vega, Mario / Cossío-Aranda, Jorge E

    Archivos de cardiologia de Mexico

    2024  Volume 94, Issue Supl 1, Page(s) 1–74

    Abstract: Chronic heart failure continues to be one of the main causes of impairment in the functioning and quality of life of people who suffer from it, as well as one of the main causes of mortality in our country and around the world. Mexico has a high ... ...

    Title translation Guía mexicana de práctica clínica para el diagnóstico y el tratamiento de la insuficiencia cardiaca.
    Abstract Chronic heart failure continues to be one of the main causes of impairment in the functioning and quality of life of people who suffer from it, as well as one of the main causes of mortality in our country and around the world. Mexico has a high prevalence of risk factors for developing heart failure, such as high blood pressure, diabetes, and obesity, which makes it essential to have an evidence-based document that provides recommendations to health professionals involved in the diagnosis and treatment of these patients. This document establishes the clinical practice guide (CPG) prepared at the initiative of the Mexican Society of Cardiology (SMC) in collaboration with the Iberic American Agency for the Development and Evaluation of Health Technologies, with the purpose of establishing recommendations based on the best available evidence and agreed upon by an interdisciplinary group of experts. This document complies with international quality standards, such as those described by the US Institute of Medicine (IOM), the National Institute of Clinical Excellence (NICE), the Intercollegiate Network for Scottish Guideline Development (SIGN) and the Guidelines International Network (G-I-N). The Guideline Development Group was integrated in a multi-collaborative and interdisciplinary manner with the support of methodologists with experience in systematic literature reviews and the development of CPG. A modified Delphi panel methodology was developed and conducted to achieve an adequate level of consensus in each of the recommendations contained in this CPG. We hope that this document contributes to better clinical decision making and becomes a reference point for clinicians who manage patients with chronic heart failure in all their clinical stages and in this way, we improve the quality of clinical care, improve their quality of life and reducing its complications.
    Language English
    Publishing date 2024-04-23
    Publishing country Mexico
    Document type Journal Article
    ZDB-ID 2059019-2
    ISSN 1665-1731 ; 1665-1731
    ISSN (online) 1665-1731
    ISSN 1665-1731
    DOI 10.24875/ACM.M24000095
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article: Recomendaciones para la atención de pacientes con insuficiencia cardiaca y COVID-19

    Cigarroa-López, José A. / Magaña-Serrano, José A. / Álvarez-Sangabriel, Amada / Ruíz-Ruíz, Vicente / Chávez-Mendoza, Adolfo / Méndez-Ortíz, Arturo / León-González, Salvador / Guízar-Sánchez, Carlos / Gutiérrez-Fajardo, Pedro / Alcocer-Gamba, Marco A.

    Arch Cardiol Mex

    Abstract: The COVID-19 pandemic decreed by the World Health Organization (WHO) since March 12, 2020 is wreaking havoc globally and it is a true economic, social and health challenge Although the clinical manifestations of COVID-19 are respiratory symptoms, some ... ...

    Abstract The COVID-19 pandemic decreed by the World Health Organization (WHO) since March 12, 2020 is wreaking havoc globally and it is a true economic, social and health challenge Although the clinical manifestations of COVID-19 are respiratory symptoms, some patients also have cardiological symptoms Among patients with cardiological conditions2 they represent a group of higher risk and, in fact, they are a particularly vulnerable group, due to their higher risk of contagion and greater severity in case of acquiring the disease1 those with heart failure (HF), including heart transplant (CT) and ventricular assists, as well as patients with pulmonary arterial hypertension (PAH) HF is the main chronic cardiovascular disease and patients in this group are the most vulnerable for the development of more serious clinical symptoms after suffering the infection, and to a greater extent cases with advanced HF3 In fact, HF is one of the most frequent complications in patients with COVID-194 Likewise, transplant patients who require immunosuppressants to avoid graft rejection, constitute a population especially susceptible to infection and to develop more serious processes This situation has made the National Association of Cardiologists of Mexico (ANCAM) and the Mexican Society of Cardiology (SMC) together with their respective chapters, have prepared the following recommendations for medical personnel, who participate in the care of this special group of patients in the different clinical settings, who suffer or not, of COVID-19
    Keywords covid19
    Publisher WHO
    Document type Article
    Note WHO #Covidence: #603316
    Database COVID19

    Kategorien

  5. Article: Recomendaciones para la atención de pacientes con insuficiencia cardiaca y COVID-19./ Recommendations for the care of patients with heart failure and COVID-19

    Cigarroa-López, José A / Magaña-Serrano, José A / Álvarez-Sangabriel, Amada / Ruíz-Ruíz, Vicente / Chávez-Mendoza, Adolfo / Méndez-Ortíz, Arturo / León-González, Salvador / Guízar-Sánchez, Carlos / Gutiérrez-Fajardo, Pedro / Alcocer-Gamba, Marco A

    Arch Cardiol Mex

    Abstract: The COVID-19 pandemic decreed by the World Health Organization (WHO) since March 12, 2020 is wreaking havoc globally and it is a true economic, social and health challenge. Although the clinical manifestations of COVID-19 are respiratory symptoms, some ... ...

    Abstract The COVID-19 pandemic decreed by the World Health Organization (WHO) since March 12, 2020 is wreaking havoc globally and it is a true economic, social and health challenge. Although the clinical manifestations of COVID-19 are respiratory symptoms, some patients also have cardiological symptoms. Among patients with cardiological conditions2 they represent a group of higher risk and, in fact, they are a particularly vulnerable group, due to their higher risk of contagion and greater severity in case of acquiring the disease1 those with heart failure (HF), including heart transplant (CT) and ventricular assists, as well as patients with pulmonary arterial hypertension (PAH). HF is the main chronic cardiovascular disease and patients in this group are the most vulnerable for the development of more serious clinical symptoms after suffering the infection, and to a greater extent cases with advanced HF3. In fact, HF is one of the most frequent complications in patients with COVID-194. Likewise, transplant patients who require immunosuppressants to avoid graft rejection, constitute a population especially susceptible to infection and to develop more serious processes. This situation has made the National Association of Cardiologists of Mexico (ANCAM) and the Mexican Society of Cardiology (SMC) together with their respective chapters, have prepared the following recommendations for medical personnel, who participate in the care of this special group of patients in the different clinical settings, who suffer or not, of COVID-19.
    Keywords covid19
    Publisher WHO
    Document type Article
    Note WHO #Covidence: #595194
    Database COVID19

    Kategorien

  6. Article: Manejo de la mediastinitis postrasplante cardiaco mediante mediastinoscopia y perlas antibióticas de liberación prolongada.

    Meza-López, Luis Raúl / Cigarroa-López, José Angel / Hernández-Meneses, Silvia / Castán-Flores, David Arturo / Mendoza-Zavala, Genaro Hiram / Barragán-Zamora, José Antonio / Carrillo-Muñoz, Arturo / Munguía-Canales, Daniel Alejandro

    Archivos de cardiologia de Mexico

    2017  Volume 87, Issue 2, Page(s) 182–186

    Title translation Dissolvable and extended release antibiotic beads in mediastinoscopic management of mediastinitis after heart transplantation.
    Language Spanish
    Publishing date 2017-04
    Publishing country Mexico
    Document type Journal Article
    ZDB-ID 2047800-8
    ISSN 1405-9940
    ISSN 1405-9940
    DOI 10.1016/j.acmx.2017.01.006
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Sodium restriction in patients with chronic heart failure and reduced ejection fraction: A randomized controlled trial.

    Ivey-Miranda, Juan B / Almeida-Gutierrez, Eduardo / Herrera-Saucedo, Raul / Posada-Martinez, Edith L / Chavez-Mendoza, Adolfo / Mendoza-Zavala, Genaro H / Cigarroa-Lopez, Jose A / Magaña-Serrano, Jose A / Rivera-Leaños, Roxana / Treviño-Mejia, Alberto / Revilla-Matute, Cristina / Flores-Umanzor, Eduardo J / Espinola-Zavaleta, Nilda / Orea-Tejeda, Arturo / Garduño-Espinosa, Juan / Saturno-Chiu, Guillermo / Rao, Veena S / Testani, Jeffrey M / Borrayo-Sanchez, Gabriela

    Cardiology journal

    2021  Volume 30, Issue 3, Page(s) 411–421

    Abstract: Background: Sodium restriction is recommended for patients with heart failure (HF) despite the lack of solid clinical evidence from randomized controlled trials. Whether or not sodium restrictions provide beneficial cardiac effects is not known.: ... ...

    Abstract Background: Sodium restriction is recommended for patients with heart failure (HF) despite the lack of solid clinical evidence from randomized controlled trials. Whether or not sodium restrictions provide beneficial cardiac effects is not known.
    Methods: The present study is a randomized, double-blind, controlled trial of stable HF patients with ejection fraction ≤ 40%. Patients were allocated to sodium restriction (2 g of sodium/day) vs. control (3 g of sodium/day). The primary outcome was change in N-terminal pro-B-type natriuretic peptide (NT-proBNP) at 20 weeks. Secondary outcomes included quality of life and adverse safety events (HF readmission, blood pressure or electrolyte abnormalities).
    Results: Seventy patients were enrolled. Median baseline sodium consumption was 3268 (2225-4537) mg/day. Adherence to the intervention based on 24-hour urinary sodium was 32%. NT-proBNP and quality of life did not significantly change between groups (p > 0.05 for both). Adverse safety events were not significantly different between the arms (p > 0.6 for all). In the per protocol analysis, patients who achieved a sodium intake < 2500 mg/day at the intervention conclusion showed improvements in NT-proBNP levels (between-group difference: -55%, 95% confidence interval -27 to -73%; p = 0.002) and quality of life (between-group difference: -11 ± 5 points; p = 0.04). Blood pressure decreased in patients with lower sodium intake (between-group difference: -9 ± 5 mmHg; p = 0.05) without significant differences in symptomatic hypotension or other safety events (p > 0.3 for all).
    Conclusions: Adherence assessed by 24-hour natriuresis and by the nutritionist was poor. The group allocated to sodium restriction did not show improvement in NT-proBNP. However, patients who achieved a sodium intake < 2500 mg/day appeared to have improvements in NT-proBNP and quality of life without any adverse safety signals.
    Clinicaltrials: gov Identifier: NCT03351283.
    MeSH term(s) Humans ; Biomarkers ; Heart Failure/diagnosis ; Heart Failure/drug therapy ; Natriuretic Peptide, Brain ; Peptide Fragments ; Quality of Life ; Sodium ; Sodium, Dietary ; Stroke Volume/physiology
    Chemical Substances Biomarkers ; Natriuretic Peptide, Brain (114471-18-0) ; Peptide Fragments ; Sodium (9NEZ333N27) ; Sodium, Dietary
    Language English
    Publishing date 2021-09-07
    Publishing country Poland
    Document type Journal Article ; Randomized Controlled Trial
    ZDB-ID 2488680-4
    ISSN 1898-018X ; 1897-5593
    ISSN (online) 1898-018X
    ISSN 1897-5593
    DOI 10.5603/CJ.a2021.0098
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Adolescents with a Favorable Mediterranean-Style-Based Pattern Show Higher Cognitive and Academic Achievement: A Cluster Analysis-The Cogni-Action Project.

    Peña-Jorquera, Humberto / Martínez-Flores, Ricardo / Espinoza-Puelles, Juan Pablo / López-Gil, José Francisco / Ferrari, Gerson / Zapata-Lamana, Rafael / Lofrano-Prado, Mara Cristina / Landaeta-Díaz, Leslie / Cigarroa, Igor / Durán-Agüero, Samuel / Cristi-Montero, Carlos

    Nutrients

    2024  Volume 16, Issue 5

    Abstract: A Mediterranean diet (MedDiet) has emerged as a crucial dietary choice, not only in attenuating various adolescents' metabolic health issues but it has also been associated with improved cognitive and academic achievement. However, few studies have ... ...

    Abstract A Mediterranean diet (MedDiet) has emerged as a crucial dietary choice, not only in attenuating various adolescents' metabolic health issues but it has also been associated with improved cognitive and academic achievement. However, few studies have established patterns of food consumption linked to both cognitive and academic achievement in adolescents living in a developing country with non-Mediterranean-based food.
    MeSH term(s) Female ; Child ; Humans ; Adolescent ; Male ; Academic Success ; Cross-Sectional Studies ; Diet, Mediterranean ; Vegetables ; Cognition ; Cluster Analysis ; Sugars
    Chemical Substances Sugars
    Language English
    Publishing date 2024-02-23
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 2518386-2
    ISSN 2072-6643 ; 2072-6643
    ISSN (online) 2072-6643
    ISSN 2072-6643
    DOI 10.3390/nu16050608
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Excerpts from the documents of Mexican positions and recommendations in cardiovascular diseases and COVID-19.

    Alcocer-Gamba, Marco A / Gutiérrez-Fajardo, Pedro / Cabrera-Rayo, Alfredo / Sosa-Caballero, Alejandro / Piña-Reyna, Yigal / Merino-Rajme, José A / Heredia-Delgado, José A / Cruz-Alvarado, Jaime E / Galindo-Uribe, Jaime / Rogel-Martínez, Ulises / González-Hermosillo, Jesús A / Ávila-Vanzzini, Nydia / Sánchez-Carranza, Jesús A / Jímenez-Orozco, Jorge H / Sahagún-Sánchez, Guillermo / Fanghänel-Salmón, Guillermo / Albores-Figueroa, Rosenberg / Carrillo-Esper, Raúl / Reyes-Terán, Gustavo /
    Cossio-Aranda, Jorge E / Borrayo-Sánchez, Gabriela / de Los Ríos, Manuel Odín / Berni-Betancourt, Ana C / Cortés-Lawrenz, Jorge / Leiva-Pons, José L / Ortiz-Fernández, Patricio H / López-Cuellar, Julio / Araiza-Garaygordobil, Diego / Madrid-Miller, Alejandra / Saturno-Chiu, Guillermo / Beltrán-Nevárez, Octavio / Enciso-Muñoz, José M / García-Rincón, Andrés / Pérez-Soriano, Patricia / Herrera-Gomar, Magali / Rosal, José J Lozoya Del / Fajardo-Juárez, Armando I / Olmos-Temois, Sergio G / Rodríguez-Reyes, Humberto / Ortiz-Galván, Fernando / Márquez-Murillo, Manlio F / Celaya-Cota, Manuel de J / Cigarroa-López, José A / Magaña-Serrano, José A / Álvarez-Sangabriel, Amada / Ruíz-Ruíz, Vicente / Chávez-Mendoza, Adolfo / Méndez-Ortíz, Arturo / León-González, Salvador / Guízar-Sánchez, Carlos / Izaguirre-Ávila, Raúl / Grimaldo-Gómez, Flavio A / Preciado-Anaya, Andrés / Ruiz-Gastélum, Edith / Fernández-Barros, Carlos L / Gordillo, Antonio / Alonso-Sánchez, Jesús / Cerón-Enríquez, Norma / Núñez-Urquiza, Juan P / Silva-Torres, Jesús / Pacheco-Beltrán, Nancy / García-Saldivia, Marianna A / Pérez-Gámez, Juan C / Lezama-Urtecho, Carlos / López-Uribe, Carlos / López-Mora, Gerardo E / Rivera-Reyes, Romina

    Archivos de cardiologia de Mexico

    2020  Volume 90, Issue Supl, Page(s) 100–110

    Abstract: The recommendations in which the Mexican Society of Cardiology (SMC) in conjunction with the National Association of Cardiologists of Mexico (ANCAM) as well as different Mexican medical associations linked to cardiology are presented, after a ... ...

    Title translation Extractos de los documentos de posicionamientos y recomendaciones mexicanas en enfermedades cardiovasculares y COVID-19.
    Abstract The recommendations in which the Mexican Society of Cardiology (SMC) in conjunction with the National Association of Cardiologists of Mexico (ANCAM) as well as different Mexican medical associations linked to cardiology are presented, after a comprehensive and consensual review and analysis of the topics related to cardiovascular diseases in the COVID-19 pandemic. Scientific positions are analyzed and responsible recommendations on general measures are given to patients, with personal care, healthy eating, regular physical activity, actions in case of cardio-respiratory arrest, protection of the patient and health personnel as well as precise indications in the use of non-invasive cardiovascular imaging, prescription of medications, care in specific topics such as systemic arterial hypertension, heart failure, arrhythmias and acute coronary syndromes, in addition to emphasizing electrophysiology, interventionism, cardiac surgery and in cardiac rehabilitation. The main interest is to provide the medical community with a general orientation on what to do in daily practice and patients with cardiovascular diseases in the setting of this unprecedented epidemiological crisis of COVID-19.
    MeSH term(s) COVID-19 ; Cardiac Rehabilitation/methods ; Cardiac Surgical Procedures/methods ; Cardiology ; Cardiovascular Diseases/physiopathology ; Cardiovascular Diseases/therapy ; Cardiovascular Diseases/virology ; Coronavirus Infections/epidemiology ; Humans ; Mexico ; Pandemics ; Pneumonia, Viral/epidemiology ; Societies, Medical
    Keywords covid19
    Language English
    Publishing date 2020-06-10
    Publishing country Mexico
    Document type Journal Article
    ISSN 1665-1731
    ISSN (online) 1665-1731
    DOI 10.24875/ACM.M20000057
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article: Extractos de los documentos de posicionamientos y recomendaciones mexicanas en enfermedades cardiovasculares y COVID-19

    Alcocer-Gamba, Marco A. / Gutiérrez-Fajardo, Pedro / Cabrera-Rayo, Alfredo / Sosa-Caballero, Alejandro / Piña-Reyna, Yigal / Merino-Rajme, José A. / Heredia-Delgado, José A. / Cruz-Alvarado, Jaime E. / Galindo-Uribe, Jaime / Rogel-Martínez, Ulises / González-Hermosillo, Jesús A. / Ávila-Vanzzini, Nydia / Sánchez-Carranza, Jesús A. / Jímenez-Orozco, Jorge H. / Sahagún-Sánchez, Guillermo / Fanghänel-Salmón, Guillermo / Albores-Figueroa, Rosenberg / Carrillo-Esper, Raúl / Reyes-Terán, Gustavo /
    Cossio-Aranda, Jorge E. / Borrayo-Sánchez, Gabriela / de Los Ríos, Manuel Odín / Berni-Betancourt, Ana C. / Cortés-Lawrenz, Jorge / Leiva-Pons, José L. / Ortiz-Fernández, Patricio H. / López-Cuellar, Julio / Araiza-Garaygordobil, Diego / Madrid-Miller, Alejandra / Saturno-Chiu, Guillermo / Beltrán-Nevárez, Octavio / Enciso-Muñoz, José M. / García-Rincón, Andrés / Pérez-Soriano, Patricia / Herrera-Gomar, Magali / Rosal, José J. Lozoya Del / Fajardo-Juárez, Armando I. / Olmos-Temois, Sergio G. / Rodríguez-Reyes, Humberto / Ortiz-Galván, Fernando / Márquez-Murillo, Manlio F. / Celaya-Cota, Manuel de J. / Cigarroa-López, José A. / Magaña-Serrano, José A. / Álvarez-Sangabriel, Amada / Ruíz-Ruíz, Vicente / Chávez-Mendoza, Adolfo / Méndez-Ortíz, Arturo / León-González, Salvador / Guízar-Sánchez, Carlos

    Arch Cardiol Mex

    Abstract: The recommendations in which the Mexican Society of Cardiology (SMC) in conjunction with the National Association of Cardiologists of Mexico (ANCAM) as well as different Mexican medical associations linked to cardiology are presented, after a ... ...

    Abstract The recommendations in which the Mexican Society of Cardiology (SMC) in conjunction with the National Association of Cardiologists of Mexico (ANCAM) as well as different Mexican medical associations linked to cardiology are presented, after a comprehensive and consensual review and analysis of the topics related to cardiovascular diseases in the COVID-19 pandemic Scientific positions are analyzed and responsible recommendations on general measures are given to patients, with personal care, healthy eating, regular physical activity, actions in case of cardio-respiratory arrest, protection of the patient and health personnel as well as precise indications in the use of non-invasive cardiovascular imaging, prescription of medications, care in specific topics such as systemic arterial hypertension, heart failure, arrhythmias and acute coronary syndromes, in addition to emphasizing electrophysiology, interventionism, cardiac surgery and in cardiac rehabilitation The main interest is to provide the medical community with a general orientation on what to do in daily practice and patients with cardiovascular diseases in the setting of this unprecedented epidemiological crisis of COVID-19
    Keywords covid19
    Publisher WHO
    Document type Article
    Note WHO #Covidence: #603320
    Database COVID19

    Kategorien

To top